Filing Flows › Comparisons › TNDM vs EMBC
Tandem Diabetes Care vs Embecta: TNDM and EMBC compared
Tandem Diabetes Care is the larger company: $284M of revenue in its latest quarter (Q3 2026) against $272M for Embecta (Q3 FY26). Tandem Diabetes Care is growing faster (+14% against -8% a year earlier). Embecta is more profitable, with an operating margin of 17.9% against -0.8%.
Where the money goes: TNDM and EMBC
Tandem Diabetes Care (TNDM) · Q3 2026
Tandem Diabetes Care, Q3 2026: revenue $284M (+14% year over year), operating margin -0.8%, net loss $7.1M, operating cash flow −$819K. The chart follows the revenue to costs, profit and cash.
Embecta (EMBC) · Q3 FY26
Embecta, Q3 FY26: revenue $272M (-8% year over year), operating margin 17.9%, net earnings $21.1M, operating cash flow $41.8M. The chart follows the revenue to costs, profit and cash.
| Tandem Diabetes Care (TNDM) | Embecta (EMBC) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 FY26 |
| Revenue | $284M | $272M |
| Revenue growth, Y/Y | +14% | -8% |
| Gross margin | — | 56.4% |
| Operating margin | -0.8% | 17.9% |
| Net earnings | −$7.1M | $21.1M |
| Net margin | -2.5% | 7.8% |
| Operating cash flow | −$819K | $41.8M |
| Free cash flow | — | $40.7M |
| Market value | $1.2B | — |
| Analysts’ mean target | $27.57 | — |
Where the revenue comes from
Tandem Diabetes Care
- Supplies and other: $169M (59%)
- Pump: $115M (41%)
Embecta
- Pen Needles: $178M (65%)
- Safety: $36.7M (14%)
- Syringes: $36.6M (13%)
- Other: $15.6M (6%)
Questions
Which is bigger, Tandem Diabetes Care or Embecta?
Tandem Diabetes Care is the larger company: $284M of revenue in its latest quarter (Q3 2026) against $272M for Embecta (Q3 FY26).
Is Tandem Diabetes Care or Embecta growing faster?
Tandem Diabetes Care is growing faster (+14% against -8% a year earlier).
Which is more profitable, Tandem Diabetes Care or Embecta?
Embecta is more profitable, with an operating margin of 17.9% against -0.8%.
More: Tandem Diabetes Care earnings · how Tandem Diabetes Care makes money · Embecta earnings · how Embecta makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 7, 2026). Fiscal quarters can end on different dates. Not investment advice.